Ergebnis 5 von 345
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Details

Autor(en) / Beteiligte
Titel
N-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice
Ist Teil von
  • PloS one, 2013-02, Vol.8 (2), p.e56233-e56233
Ort / Verlag
United States: Public Library of Science
Erscheinungsjahr
2013
Link zum Volltext
Quelle
EZB Free E-Journals
Beschreibungen/Notizen
  • We questioned if acute administration of n-3 fatty acids (FA) carried in n-3 rich triglyceride (TG) emulsions provides neuroprotection in neonatal mice subjected to hypoxic-ischemic (H/I) brain injury. We examined specificity of FA, optimal doses, and therapeutic windows for neuroprotection after H/I. H/I insult was induced in C57BL/6J 10-day-old mice by right carotid artery ligation followed by exposure to 8% O(2) for 15 minutes at 37°C. Intraperitoneal injection with n-3-rich TG emulsions, n-6 rich TG emulsions or saline for control was administered at different time points before and/or after H/I. In separate experiments, dose responses were determined with TG containing only docosahexaenoic acid (Tri-DHA) or eicosapentaenoic acid (Tri-EPA) with a range of 0.1-0.375 g n-3 TG/kg, administered immediately after H/I insult. Infarct volume and cerebral blood flow (CBF) were measured. Treatment with n-3 TG emulsions both before- and after- H/I significantly reduced total infarct volume by a mean of 43% when administered 90 min prior to H/I and by 47% when administered immediately after H/I. In post-H/I experiments Tri-DHA, but not Tri-EPA exhibited neuroprotective effects with both low and high doses (p<0.05). Moreover, delayed post-H/I treatment with Tri-DHA significantly decreased total infarct volume by a mean of 51% when administered at 0 hr, by 46% at 1 hr, and by 51% at 2 hr after H/I insult. No protective effect occurred with Tri-DHA injection at 4 hr after H/I. There were no n-3 TG related differences in CBF. A significant reduction in brain tissue death was maintained after Tri-DHA injection at 8 wk after the initial brain injury. Thus, n-3 TG, specifically containing DHA, is protective against H/I induced brain infarction when administered up to 2 hr after H/I injury. Acute administration of TG-rich DHA may prove effective for treatment of stroke in humans.
Sprache
Englisch
Identifikatoren
ISSN: 1932-6203
eISSN: 1932-6203
DOI: 10.1371/journal.pone.0056233
Titel-ID: cdi_plos_journals_1330881967
Format
Schlagworte
Animals, Animals, Newborn, Apoptosis, Biology, Bleeding Time, Blood flow, Blood Glucose - metabolism, Brain, Brain - blood supply, Brain - drug effects, Brain - pathology, Brain - physiopathology, Brain Infarction - drug therapy, Brain Infarction - pathology, Brain Infarction - physiopathology, Brain injuries, Brain injury, Cardiovascular disease, Carotid artery, Cerebral blood flow, Cerebral infarction, Cerebrovascular Circulation - drug effects, Docosahexaenoic acid, Docosahexaenoic Acids - administration & dosage, Docosahexaenoic Acids - pharmacology, Docosahexaenoic Acids - therapeutic use, Eicosapentaenoic acid, Eicosapentaenoic Acid - administration & dosage, Eicosapentaenoic Acid - pharmacology, Eicosapentaenoic Acid - therapeutic use, Emulsions, Fatty acids, Fatty Acids, Omega-3 - administration & dosage, Fatty Acids, Omega-3 - pharmacology, Fatty Acids, Omega-3 - therapeutic use, Fatty Acids, Omega-6 - administration & dosage, Fatty Acids, Omega-6 - pharmacology, Fatty Acids, Omega-6 - therapeutic use, Fish oils, Gene expression, Head injuries, Health aspects, House mouse, Hypoxia, Hypoxia-Ischemia, Brain - drug therapy, Hypoxia-Ischemia, Brain - pathology, Hypoxia-Ischemia, Brain - physiopathology, Infants (Newborn), Infarction, Injection, Injections, Intraperitoneal, Injuries, Ischemia, Laboratory animals, Lipids, Medicin och hälsovetenskap, Medicine, Metabolism, Mice, Mice, Inbred C57BL, Neonates, Neuroprotection, Neuroprotective Agents - pharmacology, Neuroprotective Agents - therapeutic use, Newborn babies, Newborn infants, Nutrition, Omega 3 fatty acids, Oxidative stress, Pediatrics, Rodents, Spinal cord injuries, Stroke, Stroke (Disease), Surgeons, Time Factors, Traumatic brain injury, Triglycerides, Triglycerides - blood, Triglycerides - pharmacology, Triglycerides - therapeutic use, Unsaturated fatty acids

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX